These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33109645)

  • 1. Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study.
    Li L; Hsu SH; Gu X; Jiang S; Shang L; Sun G; Sun L; Zhang L; Wang C; Ren Y; Wang J; Pan J; Liu J; Bin C
    BMJ Open; 2020 Oct; 10(10):e037419. PubMed ID: 33109645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
    Yu Q; Jia P; Su L; Zhao H; Que C
    BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegaloviral or
    Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC
    J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose glucocorticoid.
    Chew LC; Maceda-Galang LM; Tan YK; Chakraborty B; Thumboo J
    J Clin Rheumatol; 2015 Mar; 21(2):72-5. PubMed ID: 25710857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
    Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia.
    Enomoto T; Azuma A; Matsumoto A; Nei T; Fujita K; Hattori K; Saito Y; Abe S; Usuki J; Kudoh S
    Intern Med; 2008; 47(1):15-20. PubMed ID: 18175999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
    Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
    Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.
    Lécuyer R; Issa N; Tessoulin B; Lavergne RA; Morio F; Gabriel F; Canet E; Bressollette-Bodin C; Guillouzouic A; Boutoille D; Raffi F; Lecomte R; Le Turnier P; Deschanvres C; Camou F; Gaborit BJ;
    J Infect Dis; 2022 Mar; 225(5):868-880. PubMed ID: 34604908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognostic risk factors of mortality in patients with interstitial lung diseases and viral infection: a retrospective cohort study.
    Li L; Wang C; Sun L; Zhang X; Yang G
    J Med Microbiol; 2021 Nov; 70(11):. PubMed ID: 34738890
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection.
    Kim T; Moon SM; Sung H; Kim MN; Kim SH; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
    Scand J Infect Dis; 2012 Sep; 44(9):670-7. PubMed ID: 22264016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combine use of glucocorticoid with other immunosuppressants is a risk factor for Pneumocystis jirovecii pneumonia in autoimmune inflammatory disease patients: a meta-analysis.
    Wang H; Shui L; Chen Y
    Clin Rheumatol; 2023 Jan; 42(1):269-276. PubMed ID: 36149536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of Pneumocystis carinii pneumonia in children with systemic lupus erythematosus].
    Tang XY; Li J; Dong F; Song HM
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):920-4. PubMed ID: 24495763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
    Braga BP; Prieto-González S; Hernández-Rodríguez J
    Med Clin (Barc); 2019 Jun; 152(12):502-507. PubMed ID: 30853123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan.
    Weng CT; Liu MF; Weng MY; Lee NY; Wang MC; Lin WC; Ou CY; Lai WW; Hsu SC; Chao SC; Chung TJ; Lee CT; Shieh CC; Wang JY; Wang CR
    J Clin Rheumatol; 2013 Aug; 19(5):252-8. PubMed ID: 23872548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease.
    Ando T; Abe Y; Endo Y; Tada K; Yamaji K; Tamura N
    Mod Rheumatol; 2019 Jul; 29(4):656-661. PubMed ID: 29972334
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumocystis pneumonia in patients treated with rituximab.
    Martin-Garrido I; Carmona EM; Specks U; Limper AH
    Chest; 2013 Jul; 144(1):258-265. PubMed ID: 23258406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection.
    Muhammad Iqbal AH; Lim SK; Ng KP; Tan LP; Chong YB; Keng TC
    Transpl Infect Dis; 2012 Aug; 14(4):E23-6. PubMed ID: 22551151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors.
    Boonsarngsuk V; Sirilak S; Kiatboonsri S
    Int J Infect Dis; 2009 Jan; 13(1):59-66. PubMed ID: 18573675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.